SMART-Exos displaying bispecific antibodies (anti-CD3/anti-EGFR or anti-CD3/anti-HER2) enable simultaneous T cell activation and redirection toward tumour cells, and CD40L-expressing exosomes further boost dendritic cell maturation and cytokine secretion (42). The gene discussed is EGFR; the disease is neoplasm.